| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
AmylinPramlintideAdrenomedullinCalcitonin gene related peptideNutrition (Neuroendokrinology)GlucagonInsulin (BASKET)beta cell (Pancreas)Diabetes mellitus T2DM (Type2)| 1 | 2008 | Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk. | 
| + | - | nl | Vasc Health Risk Manag 4(2):355-62 (2008) Hoogwerf BJ |
| 2 | 2002 | International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. | 
| + | - | nl | Pharmacol Rev 54(2):233-46 (2002) |
| 3 | 2004 | Amylin agonists: a novel approach in the treatment of diabetes. | 
| + | - | nl | Diabetes 53 Suppl 3():S233-8 (2004) Schmitz O |
| 4 | 2006 | Pancreatic signals controlling food intake; insulin, glucagon and amylin. | 
| + | - | nl | Philos Trans R Soc Lond B Biol Sci 361(1471):1219-35 (2006) Woods SC |
| 5 | 2008 | Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. | 
| + | - | nl | Endocr Rev 29(3):303-16 (2008) Haataja L |